IDXX Idexx Laboratories Загрузка... : Бычьи и медвежьи мнения аналитиков
Загрузка графика...
Лучшие сигналы
Лента
06:14
05 авг
05 авг
Author long IDEXX from recent lows
Buy IDEXX Laboratories; author discloses an active long position entered from recent lows over the past few weeks, maintaining a cautiously bullish stance within a hedged portfolio framework.
Сред.
12:30
04 авг
04 авг
Management raised full-year organic revenue and EPS guidance midpoint, citing continued strong recurring revenue momentum, innovation traction (InViewDX, CancerDx, Catalyst menu), and planned investments in international commercial expansion.
Выс.
13:30
12 фев
12 фев
Management notes that US owner economics are being squeezed by escalating veterinary clinic prices, which is driving a decline in routine care visits and accelerating a shift toward emergency/urgent care and value-focused, alternative care models. — A structural slowdown in routine veterinary visits in the US could dampen the volume of products sold through traditional clinics, pressuring companies with high US companion-animal exposure and shifting demand toward retail/online channels and urgent care centers.
Сред.
13:30
02 фев
02 фев
Management's guidance for 2026 is positive, expecting 7-9% organic revenue growth and 10-14% EPS growth, driven by continued innovation adoption and commercial execution despite macro headwinds.
Выс.
Об аналитическом покрытии IDXX
Buzzberg отслеживает IDXX (Idexx Laboratories) в 3 источниках. Бычьих сигналов: 1, медвежьих: 0, от 4 аналитиков. Сентимент преимущественно бычий (20%). Всего отслеживается 5 торговых идей. За последние 7 дней: бычьих: 1, наблюдение: 1. Последние спикеры: asklivermore, Andrew Emerson, tacticzh.